Sale!

GCH1 Gene DYT5A Genetic Test

4,400 د.إ

-21%

The GCH1 Gene DYT5A Genetic Test is a specialized diagnostic tool designed to identify mutations in the GCH1 gene, which are associated with DYT5A, also known as Segawa syndrome or dopa-responsive dystonia. This condition is a rare, inherited disorder characterized by dystonia, tremors, and issues with gait that typically responds well to treatment with levodopa, a medication commonly used to treat Parkinson’s disease. The test involves analyzing the patient’s DNA to detect any genetic variations in the GCH1 gene that may lead to the development of DYT5A.

Performed at DNA Labs UAE, a leading facility in genetic testing, this test provides crucial information for the accurate diagnosis and management of individuals suspected to have dopa-responsive dystonia. With a cost of 4400 AED, the test is an investment in gaining a comprehensive understanding of the genetic underpinnings of the condition, which can significantly impact treatment decisions and outcomes. DNA Labs UAE employs cutting-edge technology and expertise to ensure reliable and accurate test results, making it a trusted choice for patients and healthcare providers seeking genetic testing services.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GCH1 Gene DYT5A Genetic Test

Test Name: GCH1 Gene DYT5A Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GCH1 Gene DYT5A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GCH1 Gene DYT5A

Test Details

The GCH1 gene is associated with the development of DYT5A, also known as Segawa syndrome or dopa-responsive dystonia. DYT5A is a rare genetic disorder that affects the nervous system, causing movement problems such as muscle stiffness, tremors, and difficulty with coordination.

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the GCH1 gene that may be responsible for DYT5A. This type of genetic testing uses advanced technology to analyze multiple genes at once, allowing for more comprehensive and accurate results.

Identifying a mutation in the GCH1 gene can help with the diagnosis of DYT5A and guide treatment options. In some cases, medications that increase the levels of dopamine in the brain can be effective in managing symptoms.

It is important to note that genetic testing is not always necessary for the diagnosis of DYT5A, as other diagnostic tests and clinical evaluations can also be used. Genetic counseling may also be recommended for individuals and families affected by DYT5A to better understand the inheritance pattern and potential risks for future generations.

Test Name GCH1 Gene DYT5A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GCH1 Gene DYT5A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GCH1 Gene DYT5A
Test Details

The GCH1 gene is associated with the development of DYT5A, also known as Segawa syndrome or dopa-responsive dystonia. DYT5A is a rare genetic disorder that affects the nervous system, causing movement problems such as muscle stiffness, tremors, and difficulty with coordination.

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the GCH1 gene that may be responsible for DYT5A. This type of genetic testing uses advanced technology to analyze multiple genes at once, allowing for more comprehensive and accurate results.

Identifying a mutation in the GCH1 gene can help with the diagnosis of DYT5A and guide treatment options. In some cases, medications that increase the levels of dopamine in the brain can be effective in managing symptoms.

It is important to note that genetic testing is not always necessary for the diagnosis of DYT5A, as other diagnostic tests and clinical evaluations can also be used. Genetic counseling may also be recommended for individuals and families affected by DYT5A to better understand the inheritance pattern and potential risks for future generations.